Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Yamasaki

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Anticancer Research|May 6, 2009
The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusionsJunji Wada, Hiroyuki Suzuki, Ryouta Fuchino, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancerHiroyuki Suzuki, Nobuhito Chikazawa, Takehiko Tasaka, et al.
Anticancer Research|August 1, 2018
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung CancerHideya Onishi, Shu Ichimiya, Kosuke Yanai, et al.
Anticancer Research|May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic CancerHideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of ShhAkio Yamasaki, Chizu Kameda, Rui Xu, et al.
Anticancer Research|August 30, 2008
Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patientsJunji Wada, Akio Yamasaki, Shuntaro Nagai, et al.
Journal of Surgical Oncology|September 2, 2009
Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathwayMio Ikebe, Yoshiki Kitaura, Masafumi Nakamura, et al.
Anticancer Research|May 6, 2009
A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft modelAkio Yamasaki, Momoko Shoda, Hiroko Iijima, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Anticancer Research|May 6, 2009
The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusionsJunji Wada, Hiroyuki Suzuki, Ryouta Fuchino, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancerHiroyuki Suzuki, Nobuhito Chikazawa, Takehiko Tasaka, et al.
Anticancer Research|August 1, 2018
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung CancerHideya Onishi, Shu Ichimiya, Kosuke Yanai, et al.
Anticancer Research|May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic CancerHideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of ShhAkio Yamasaki, Chizu Kameda, Rui Xu, et al.
Anticancer Research|August 30, 2008
Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patientsJunji Wada, Akio Yamasaki, Shuntaro Nagai, et al.
Journal of Surgical Oncology|September 2, 2009
Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathwayMio Ikebe, Yoshiki Kitaura, Masafumi Nakamura, et al.
Anticancer Research|May 6, 2009
A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft modelAkio Yamasaki, Momoko Shoda, Hiroko Iijima, et al.
Pageof 3